184 related articles for article (PubMed ID: 27333037)
1. Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury.
Gao F; Fang J; Chen F; Wang C; Chen S; Zhang S; Lv X; Zhang J; He Q; Weng S; Liu Q; Lin XH
EBioMedicine; 2016 Jul; 9():324-335. PubMed ID: 27333037
[TBL] [Abstract][Full Text] [Related]
2. Adropin deficiency worsens HFD-induced metabolic defects.
Chen S; Zeng K; Liu QC; Guo Z; Zhang S; Chen XR; Lin JH; Wen JP; Zhao CF; Lin XH; Gao F
Cell Death Dis; 2017 Aug; 8(8):e3008. PubMed ID: 28837146
[TBL] [Abstract][Full Text] [Related]
3. Serum adropin level and ENHO gene expression in systemic sclerosis.
Yolbas S; Kara M; Yilmaz M; Aydin S; Koca SS
Clin Rheumatol; 2016 Jun; 35(6):1535-40. PubMed ID: 27079850
[TBL] [Abstract][Full Text] [Related]
4. ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus.
Yolbas S; Kara M; Kalayci M; Yildirim A; Gundogdu B; Aydin S; Koca SS
Adv Clin Exp Med; 2018 Dec; 27(12):1637-1641. PubMed ID: 30141839
[TBL] [Abstract][Full Text] [Related]
5. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
6. ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients.
Grzegorzewska AE; Niepolski L; Świderska MK; Mostowska A; Stolarek I; Warchoł W; Figlerowicz M; Jagodziński PP
BMC Med Genet; 2018 Nov; 19(1):194. PubMed ID: 30413149
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Shuai ZW; Lv YF; Zhang MM; Hu ZY
Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
[TBL] [Abstract][Full Text] [Related]
8. Involvement of adropin and adropin-associated genes in metabolic abnormalities of hemodialysis patients.
Grzegorzewska AE; Niepolski L; Mostowska A; Warchoł W; Jagodziński PP
Life Sci; 2016 Sep; 160():41-46. PubMed ID: 27449397
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
Gan PY; Holdsworth SR; Kitching AR; Ooi JD
Cell Immunol; 2013 Mar; 282(1):21-7. PubMed ID: 23665205
[TBL] [Abstract][Full Text] [Related]
10. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
[TBL] [Abstract][Full Text] [Related]
11. No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
Fiebeler A; Borgmann S; Woywodt A; Haller H; Haubitz M
Nephrol Dial Transplant; 2004 Apr; 19(4):969-71. PubMed ID: 15031357
[TBL] [Abstract][Full Text] [Related]
12. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis.
Ando M; Miyazaki E; Ishii T; Mukai Y; Yamasue M; Fujisaki H; Ito T; Nureki S; Kumamoto T
Respir Med; 2013 Apr; 107(4):608-15. PubMed ID: 23434037
[TBL] [Abstract][Full Text] [Related]
13. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
Ooi JD; Gan PY; Chen T; Eggenhuizen PJ; Chang J; Alikhan MA; Odobasic D; Holdsworth SR; Kitching AR
Kidney Int; 2014 Dec; 86(6):1140-9. PubMed ID: 24869670
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Hasegawa M; Nishii C; Ohashi A; Tomita M; Nakai S; Murakami K; Nabeshima K; Fujita Y; Ishii J; Hiki Y; Sugiyama S
Nephron Clin Pract; 2009; 113(3):c222-33. PubMed ID: 19690440
[TBL] [Abstract][Full Text] [Related]
15. Selective deficiency of UCP-1 and adropin may lead to different subtypes of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Chen Q; Li Y; Guo X; Liu Y; Guo Y; Lv X; Lin Y; Liu Q
Genes Immun; 2023 Feb; 24(1):39-45. PubMed ID: 36670189
[TBL] [Abstract][Full Text] [Related]
16. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.
Kumar KG; Trevaskis JL; Lam DD; Sutton GM; Koza RA; Chouljenko VN; Kousoulas KG; Rogers PM; Kesterson RA; Thearle M; Ferrante AW; Mynatt RL; Burris TP; Dong JZ; Halem HA; Culler MD; Heisler LK; Stephens JM; Butler AA
Cell Metab; 2008 Dec; 8(6):468-81. PubMed ID: 19041763
[TBL] [Abstract][Full Text] [Related]
17. ANCA: associated lung fibrosis.
Yamada H
Semin Respir Crit Care Med; 2011 Jun; 32(3):322-7. PubMed ID: 21674417
[TBL] [Abstract][Full Text] [Related]
18. Serum B-cell activating factor in myeloperoxiase-antineutrophil cytoplasmic antibodies-associated vasculitis.
Xin G; Chen M; Su Y; Xu LX; Zhao MH; Li KS
Am J Med Sci; 2014 Jul; 348(1):25-9. PubMed ID: 24534784
[TBL] [Abstract][Full Text] [Related]
19. Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients.
Baskin E; Bakkaloglu A; Besbas N; Hascelik G; Saatci U; Gök F; Ozen S
Pediatr Nephrol; 2002 Nov; 17(11):917-9. PubMed ID: 12432434
[TBL] [Abstract][Full Text] [Related]
20. Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients.
Ando Y; Okada F; Matsumoto S; Mori H
J Comput Assist Tomogr; 2004; 28(5):710-6. PubMed ID: 15480049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
